POZ IRELAND

Home Up Contents News About Us

gpi@poz.iol.ie

 

Home
Basic Message
Laboratory Tests
Viral Load
When to start treatment?
Treatments
Anti-HIV Drugs
Drugs and Doses
Side Effects
Treatment Changes
Salvage Therapy
Infections
Vaccinations
Lipodystrophy
Micronutrition
Women & HIV
Glossary

 

 

Home ] Up ] Genotype Testing ] Phenotype Testing ]

 HIV DRUG RESISTANCE TESTS 

 

Resistance testing is to measure resistance of HIV to antiretroviral drugs. Resistance testing can aid in antiretroviral drug selection but has certain limitations.

 

Resistance testing identifies drugs that should be avoided, but not necessarily the drugs that are most likely to be active.

Testing should be done in the presence of the antiretroviral agents in question, as discontinuation of therapy often results in the proliferation of wild type virus that could suggest susceptibility. The time between discontinuation of HAART and the shift from resistant strains to wild type virus is usually 2-8 weeks, though there is considerable variation depending on the specific mutation.

Interpretation of results in people who have received prior antiretroviral agents is difficult. Resistance to previously used drugs may be present even if resistance assays indicate susceptibility.

A viral load >500 to 1000 c/ml is usually required.

Results are more accurate with failure of early regimens.

 

There are two types of tests: genotypic and phenotypic tests. The most commonly used test is the genotypic test, because results are available more quickly, the test is less expensive and are more readily available. A potential advantage of phenotypic tests is that results are more easily interpreted. The advantages and disadvantages of these tests are shown on the following links:

genotype testing

phenotype testing

 

Full Blood Count ] Lipids & Others ] [ Resistance Tests ] Liver Function Tests ] CD4 Counts ]

Home ] Up ] Genotype Testing ] Phenotype Testing ]

Copyright © 2005 Poz Ireland